BioSpace News Archive

IsoPlexis Corporation, a leader in functional single-cell proteomics, announced the closing of its initial public offering of 8,333,000 shares of common stock at a public offering price of $15.00 per share.

LogicBio Therapeutics, Inc. (Nasdaq:LOGC), today announced that it was selected to present new data from the company’s GeneRide™ platform in a plenary oral presentation and three poster presentations at the upcoming European Society of Gene and Cell Therapy (ESGCT) Virtual Congress 2021.,

Ortho Clinical Diagnostics Holdings plc, one of the world’s largest pure-play in vitro diagnostics companies, announced it will report results for its third quarter 2021 ended October 3, 2021, after the market close on Wednesday, November 3, 2021.

AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological, COVID-19 and dry eye disease (DED) diagnostics, today announced the development of the second generation version of its Rapid Neutralizing Antibody Test for COVID-19.

Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval and clearance in the last month for its Cochlear™ Remote Assist solution in the Nucleus® and Baha® Systems.

Horizon Therapeutics plc (Nasdaq: HZNP) today announced new TEPEZZA data will be presented at the American Academy of Ophthalmology Annual Meeting (AAO 2021) in New Orleans and virtually, Nov. 12-15, 2021.

Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, announced that its Chief Executive Officer Waqaas Al Siddiq is scheduled to present in-person at the Virtual LD Micro Main Event XIV in-person on Wednesday, October 13, 2021 at 5:00 PM PT/ 8:00 PM ET.

DarwinHealth, Inc. today announced a scientific research collaboration employing its Biomarker Enrichment Strategies for Trials (BEST platform) to elucidate novel biomarkers to guide translational trajectories for multiple oncology molecules being developed by Prelude Therapeutics.

Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced it has won a 2021 Orthopedics This Week Spine Technology Award for its new Angled Endplate implants for the prodisc® L Lumbar Total Disc Replacement System.

Hoth Therapeutics, Inc. today announced that is has received Human Research Ethics Committee (HREC) clearance to commence cohort 2 of the Phase 1b clinical trial of BioLexa Lotion for the treatment of mild to moderate atopic dermatitis in Australia.